doctor head
 
  pharmacy and drugs  
search Search
 
       About us       News      A-Z Drugs      Stores      Top Drugs      Contact  
  doctor doctor hand
 
  doctor legs  
 
 
 
 

  Diseases

  Newsletter
Subscribe to our newsletter:
Name:
E-mail:

    Zantac
Zantac Zantac review
by
Pharmacy and Drugs


     .: Prescription

Zantac is a histamine H2-receptor antagonist that inhibits stomach acid production, and commonly used in the treatment of peptic ulcer disease (PUD) and gastroesophageal reflux disease (GERD). It is currently marketed by GlaxoSmithKline under the trade name Zantac.

There most important we should know before using these drug for medication is to tell your doctor if you have kidney or liver disease, porphyria, diabetes, lung disease, or a weak immune system. If you have any of the conditions listed above, you may not be able to use ranitidine or you may need a dosage adjustment or special monitoring during treatment. Using this medication may make you more susceptible to pneumonia if you have diabetes, lung disease, a weak immune system, or if you are elderly. Talk with your doctor about your individual risk.

Ranitidine effervescent tablets must be dissolved in water before you take them. The doctor may recommend an antacid to help relieve pain. Carefully follow your doctor's directions about the type of antacid to use, and when to use it. We should not stop taking ranitidine without asking your doctor. It may take up to 8 weeks for an ulcer to heal.

Ranitidine is in the FDA pregnancy category B. This means that it is not expected to be harmful to an unborn baby. Do not use this medication without telling your doctor if you are pregnant or plan to become pregnant during treatment. Ranitidine passes into breast milk. Do not take ranitidine without telling your doctor if you are breast-feeding a baby. This medication can cause you to have unusual results with certain medical tests. Tell any doctor who treats you that you are using ranitidine.

You should take what the doctor exactly prescribe you. Do not use more of the medication than recommended. Do not take ranitidine for longer than your doctor has prescribed. Take each ranitidine tablet with a full glass of water. The ranitidine effervescent tablet or granules must be dissolved in water before taking each dose. Tablets or granules should not be chewed, swallowed whole, or dissolved on the tongue.

Place the Zantac 150 mg EFFERdose tablet in a full glass (6 to 8 ounces) of water. Allow the tablet to completely dissolve, then drink the entire mixture. The Zantac 25 mg EFFERdose tablet in at least 1 teaspoon of water. Allow the tablet to completely dissolve, then drink the entire mixture. If you are giving this medicine to a child, you can place this mixture in a medicine dropper or syringe before giving it to the child.

Take the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed dose and take the medicine at the next regularly scheduled time. Do not take extra medicine to make up the missed dose. And if overdose happen. Seek emergency medical attention if you think you have used too much of this medicine.

Each ZANTAC 150 Tablet for oral administration contains 168 mg of ranitidine HCl equivalent to 150 mg of ranitidine. Each tablet also contains the inactive ingredients FD&C Yellow No. 6 Aluminum Lake, hypromellose, magnesium stearate, microcrystalline cellulose, titanium dioxide, triacetin, and yellow iron oxide.
Each ZANTAC 300 Tablet for oral administration contains 336 mg of ranitidine HCl equivalent to 300 mg of ranitidine. Each tablet also contains the inactive ingredients croscarmellose sodium, D&C Yellow No. 10 Aluminum Lake, hypromellose, magnesium stearate, microcrystalline cellulose, titanium dioxide, and triacetin.
ZANTAC 25 EFFERdose Tablets for oral administration is an effervescent formulation of ranitidine that must be dissolved in water before use. Each individual tablet contains 28 mg of ranitidine HCl equivalent to 25 mg of ranitidine and the following inactive ingredients: aspartame, monosodium citrate anhydrous, povidone, and sodium bicarbonate. Each tablet also contains sodium benzoate. The total sodium content of each tablet is 30.52 mg (1.33 mEq) per 25 mg of ranitidine.
ZANTAC 150 EFFERdose Tablets for oral administration is an effervescent formulation of ranitidine that must be dissolved in water before use. Each individual tablet contains 168 mg of ranitidine HCl equivalent to 150 mg of ranitidine and the following inactive ingredients: aspartame, monosodium citrate anhydrous, povidone, and sodium bicarbonate. Each tablet also contains sodium benzoate. The total sodium content of each tablet is 183.12 mg (7.96 mEq) per 150 mg of ranitidine.
Each 1 mL of ZANTAC Syrup contains 16.8 mg of ranitidine HCl equivalent to 15 mg of ranitidine. ZANTAC Syrup also contains the inactive ingredients alcohol (7.5%), butylparaben, dibasic sodium phosphate, hypromellose, peppermint flavor, monobasic potassium phosphate, propylparaben, purified water, saccharin sodium, sodium chloride, and sorbitol.

Zantac has the following structural formula:

Zantac chemical structure
Generic name: Ranitidine

Brand name(s): Zantac 150 :: Zantac 300 :: Zantac 300 GELdose :: Zantac 75 :: Zantac EFFERdose :: Zantac GELdose

Similar drugs: Pantoprazole :: Aciphex :: Levbid

  Add Comment
Tell others what you thought about Zantac.

Nick: Score:
Text:

2006-2012 pharmacy-and-drugs.com. All rights reserved.